MaxLife review: the starter price and the notice needed to cancel

MaxLife’s price headlines are tied to a Starter Kit Plan: compounded semaglutide starts at $89 per month and compounded tirzepatide at $120. Those are entry offers. The public pages reviewed do not establish one complete charge and renewal schedule that applies to every patient.

Steady Shot checked MaxLife’s public treatment pages and terms on October 15, 2026. This is a document-based review, not an account of taking medication or testing customer service. We did not buy a plan, receive an individualized prescription or verify the full checkout total. We therefore do not assign a care-quality score.

Start with the complete kit price

The semaglutide page qualifies its $89 headline with a Starter Kit Plan footnote; the tirzepatide page does the same for $120. Neither headline alone tells a reader the number of months prepaid, the quantity dispensed or the next standard charge. Multiplying the advertised figure by twelve would not produce a verified annual quote.

The FAQ says the membership covers the prescription, supplies and priority shipping. It also says shipment frequency depends on the billing period and prescribed dose: some patients receive monthly shipments, others quarterly. A three-month shipment does not itself prove that the account is billed quarterly or that each remaining month is refundable.

For a clinically approved increase in dose, the page says the prescription and membership will be adjusted accordingly. It does not promise a fixed price for every future regimen. Ask for the first total, next total, payment frequency, supply duration and any separate testing charge before comparing this offer with another provider’s monthly price.

Thirty days of notice changes the meaning of cancel anytime

The treatment FAQ says there is no long-term contract, but cancellation requires notice at least thirty days before the next billing period begins. The terms of service, last dated September 11, 2024 on the public page, also require thirty days’ notice before the intended cancellation date. They direct the request to the support contact listed there.

The terms say subscriptions renew at the frequency shown on the subscription page, or monthly if none is designated, at then-current rates. Do not assume that an email just before the next charge will stop it. Obtain the exact next billing date, the latest acceptable notice date and written confirmation of the cancellation.

Subscription payments generally have no refunds or credits for partially used periods. After cancellation, access continues through the already-paid period. The terms separately promise a refund of amounts paid if the person is deemed ineligible for the service. That exception should not be read as a broad money-back promise for someone who receives medication but later chooses to stop.

The terms also discuss applicable early-termination fees when the company terminates an account for nonpayment or a breach, without giving a universal amount. Ask which fees, if any, are part of the selected plan. Stopping a card payment is not equivalent to completing the stated cancellation process.

The platform names pharmacy partners, but the actual assignment matters

MaxLife identifies itself in the terms as MaxLife Technologies Inc. and affiliated medical groups. Its treatment pages describe a platform that facilitates care, rather than a drug manufacturer or dispensing pharmacy. They name Hallandale Pharmacy, Red Rock Pharmacy and Strive Pharmacy as partners.

A partner list is useful context but not proof that a particular order comes from any one of them. Ask for the actual medical practice, prescriber and dispensing pharmacy, then check the relevant licenses. MaxLife advertises service in all fifty states; this review did not independently verify product-by-product or state-by-state availability.

Approval, processing and delivery are separate intervals

MaxLife says provider approval usually occurs within twenty-four hours. Its FAQ separately describes an average of two to three business days for the pharmacy to process and ship an in-stock order, while the offer advertises free overnight shipping. These statements describe successive stages, not an independently verified next-day arrival from the moment of enrollment.

The program advertises ongoing provider messaging and side-effect support, but those services do not have a verified response-time measurement in this review. For storage and a delayed or warm shipment, use the dispensing pharmacy’s product-specific instructions rather than extrapolating from a general shipping statement.

Read the medical marketing within its limits

The reviewed offers are compounded preparations, not FDA-approved Wegovy or Zepbound. The FDA explains that compounded drugs do not undergo its premarket review for safety, effectiveness or quality. Naming a licensed pharmacy does not change that approval status.

MaxLife refers to branded-drug trials and also claims its added B vitamins help reduce gastrointestinal side effects. The reviewed pages do not provide product-specific clinical evidence establishing that benefit for the dispensed combination. Neither the branded trial averages nor a patient testimonial predicts what an individual will experience with this preparation.

The practical next step is a written plan quote paired with the clinician’s product explanation: what is prescribed, who dispenses it, what each charge buys and when cancellation must arrive. Compare those details with the LumiMeds review, where the key unresolved issue is the relationship between the product offer and the membership commitment.